Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
07 2021
Historique:
revised: 09 05 2021
received: 12 03 2021
accepted: 11 05 2021
pubmed: 7 6 2021
medline: 16 10 2021
entrez: 6 6 2021
Statut: ppublish

Résumé

We aimed to characterize the clinical profile and outcomes of new onset refractory status epilepticus (NORSE) in children, and investigated the relationship between fever onset and status epilepticus (SE). Patients with refractory SE (RSE) between June 1, 2011 and October 1, 2016 were prospectively enrolled in the pSERG (Pediatric Status Epilepticus Research Group) cohort. Cases meeting the definition of NORSE were classified as "NORSE of known etiology" or "NORSE of unknown etiology." Subgroup analysis of NORSE of unknown etiology was completed based on the presence and time of fever occurrence relative to RSE onset: fever at onset (≤24 h), previous fever (2 weeks-24 h), and without fever. Of 279 patients with RSE, 46 patients met the criteria for NORSE. The median age was 2.4 years, and 25 (54%) were female. Forty (87%) patients had NORSE of unknown etiology. Nineteen (48%) presented with fever at SE onset, 16 (40%) had a previous fever, and five (12%) had no fever. The patients with preceding fever had more prolonged SE and worse outcomes, and 25% recovered baseline neurological function. The patients with fever at onset were younger and had shorter SE episodes, and 89% recovered baseline function. Among pediatric patients with RSE, 16% met diagnostic criteria for NORSE, including the subcategory of febrile infection-related epilepsy syndrome (FIRES). Pediatric NORSE cases may also overlap with refractory febrile SE (FSE). FIRES occurs more frequently in older children, the course is usually prolonged, and outcomes are worse, as compared to refractory FSE. Fever occurring more than 24 h before the onset of seizures differentiates a subgroup of NORSE patients with distinctive clinical characteristics and worse outcomes.

Identifiants

pubmed: 34091885
doi: 10.1111/epi.16950
pmc: PMC8362203
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1629-1642

Informations de copyright

© 2021 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Références

JAMA Neurol. 2018 Apr 1;75(4):410-418
pubmed: 29356811
J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):820-2
pubmed: 25398790
Ann Neurol. 2019 Apr;85(4):526-537
pubmed: 30779222
J Neurol Sci. 2016 Sep 15;368:272-6
pubmed: 27538648
Epilepsia. 2012 Jan;53(1):101-10
pubmed: 22191582
Acta Neurol Scand. 2010 Apr;121(4):251-6
pubmed: 20028339
Epilepsy Res. 2006 Apr;69(1):67-79
pubmed: 16469483
Neurology. 2015 Oct 6;85(14):1224-32
pubmed: 26341869
Pediatrics. 1989 Mar;83(3):323-31
pubmed: 2919138
Epilepsia. 2018 Apr;59(4):739-744
pubmed: 29399791
Pediatrics. 2012 Sep;130(3):e501-6
pubmed: 22908107
Seizure. 2013 Sep;22(7):553-9
pubmed: 23643626
Neurology. 2008 Jul 15;71(3):170-6
pubmed: 18525033
Front Neurol. 2017 Mar 27;8:111
pubmed: 28396650
Epilepsy Behav. 2015 Jun;47:17-23
pubmed: 26010959
Epilepsia. 2021 Jul;62(7):1629-1642
pubmed: 34091885
Epilepsia. 2015 Oct;56(10):1515-23
pubmed: 26336950
Neuropediatrics. 2017 Feb;48(1):5-18
pubmed: 27919115
Neurology. 2002 Feb 26;58(4):537-41
pubmed: 11865129
JAMA Neurol. 2021 May 1;78(5):588-595
pubmed: 33818596
Seizure. 2014 Feb;23(2):87-97
pubmed: 24183923
Ann Neurol. 2002 Sep;52(3):303-10
pubmed: 12205642
Dev Med Child Neurol. 2011 Nov;53(11):1053-7
pubmed: 21592118
Neurology. 2012 Nov 27;79(22):2180-6
pubmed: 23136262
Brain Dev. 2010 Jan;32(1):51-6
pubmed: 19850427
Dev Med Child Neurol. 1997 Oct;39(10):652-8
pubmed: 9352725
Epilepsia. 2019 May;60(5):911-920
pubmed: 30980677
Epilepsia. 2008 Apr;49(4):615-25
pubmed: 18093148
Lancet. 2006 Jul 15;368(9531):222-9
pubmed: 16844492
Ann Indian Acad Neurol. 2016 Apr-Jun;19(2):188-94
pubmed: 27293328
Epilepsia. 2011 Nov;52(11):1956-65
pubmed: 21883180
BMJ. 2015 Aug 18;351:h4240
pubmed: 26286537
Neuropediatrics. 2005 Jun;36(3):186-92
pubmed: 15944904
Epilepsia. 2010 Jul;51(7):1323-8
pubmed: 20345937
Epilepsia. 2013 Sep;54 Suppl 6:54-6
pubmed: 24001074
Seizure. 2013 Apr;22(3):217-20
pubmed: 23333762
Neurology. 2015 Nov 3;85(18):1604-13
pubmed: 26296517
J Neurol Sci. 2009 Feb 15;277(1-2):26-31
pubmed: 19013586
Neurocrit Care. 2008;9(1):74-82
pubmed: 18097641
Seizure. 2003 Sep;12(6):379-87
pubmed: 12915084
J Child Neurol. 2005 Mar;20(3):184-7
pubmed: 15832606

Auteurs

Claudine Sculier (C)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Department of Neurology, Erasmus Hospital, Free University of Brussels, Brussels, Belgium.

Cristina Barcia Aguilar (C)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Department of Child Neurology, La Paz University Hospital, Autonomous University of Madrid, Madrid, Spain.

Nicolas Gaspard (N)

Department of Neurology, Erasmus Hospital, Free University of Brussels, Brussels, Belgium.
Neurology Department, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, CT, USA.

Marina Gaínza-Lein (M)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Faculty of Medicine, Institute of Pediatrics, Austral University of Chile, Valdivia, Chile.
Children's Neuropsychiatry Service, San Borja Arriarán Clinical Hospital, University of Chile, Santiago, Chile.

Iván Sánchez Fernández (I)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Department of Child Neurology, SJD Barcelona Children's Hospital, University of Barcelona, Barcelona, Spain.

Marta Amengual-Gual (M)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Pediatric Neurology Unit, Department of Pediatrics, Son Espases University Hospital, University of the Balearic Islands, Palma, Spain.

Anne Anderson (A)

Section of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

Ravindra Arya (R)

Division of Pediatric Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Brian T Burrows (BT)

Department of Pediatrics, Barrows Neurological Institute, Phoenix Children's Hospital, University of Arizona School of Medicine, Phoenix, AZ, USA.
Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA.

James N Brenton (JN)

Department of Neurology and Pediatrics, University of Virginia Health System, Charlottesville, Virginia, USA.

Jessica L Carpenter (JL)

Center for Neuroscience, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Kevin E Chapman (KE)

Departments of Pediatrics and Neurology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA.

Justice Clark (J)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

William D Gaillard (WD)

Center for Neuroscience, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Tracy A Glauser (TA)

Division of Pediatric Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Joshua L Goldstein (JL)

Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program, Northwestern University Feinberg, School of Medicine, Chicago, IL, USA.

Howard P Goodkin (HP)

Department of Neurology and Pediatrics, University of Virginia Health System, Charlottesville, Virginia, USA.

Mark Gorman (M)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Yi-Chen Lai (YC)

Section of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

Tiffani L McDonough (TL)

Division of Neurology and Epilepsy, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Mohamad A Mikati (MA)

Division of Pediatric Neurology, Duke University Medical Center, Duke University, Durham, NC, USA.

Anuranjita Nayak (A)

Section of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

Katrina Peariso (K)

Division of Pediatric Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

James Riviello (J)

Section of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

Allison Rusie (A)

Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program, Northwestern University Feinberg, School of Medicine, Chicago, IL, USA.

Katherine Sperberg (K)

Center for Neuroscience, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Coral M Stredny (CM)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Robert C Tasker (RC)

Department of Neurology, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Dmitry Tchapyjnikov (D)

Division of Neurology and Epilepsy, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Alejandra Vasquez (A)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Division of Child and Adolescent Neurology, Mayo Clinic, Mayo Clinic School of Medicine, Rochester, MN, USA.

Mark S Wainwright (MS)

Division of Pediatric Neurology, Department of Neurology, University of Washington, Seattle, WA, USA.

Angus A Wilfong (AA)

Division of Pediatric Neurology, Department of Child Health, Phoenix Children's Hospital, University of Arizona College of Medicine, Phoenix, AZ, USA.

Korwyn Williams (K)

Division of Pediatric Neurology, Department of Child Health, Phoenix Children's Hospital, University of Arizona College of Medicine, Phoenix, AZ, USA.

Tobias Loddenkemper (T)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH